Functional biomarkers in cervical precancer: an overview (Q37639296)

21 August 2017

1 reference

title

Functional biomarkers in cervical precancer: an overview (English)

1 reference

21 August 2017

0 references

2

Radhika Srinivasan

1 reference

21 August 2017

Nalini Gupta

1

1 reference

21 August 2017

Arvind Rajwanshi

series ordinal

3

1 reference

21 August 2017

publication date

1 August 2010

1 reference

21 August 2017

published in

Diagnostic Cytopathology

1 reference

21 August 2017

volume

38

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

618-623

1 reference

Biomarkers in cervical cancer screening

21 August 2017

cites work

1 reference

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

21 January 2018

1 reference

Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions

21 January 2018

1 reference

Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation

21 January 2018

1 reference

Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens

21 January 2018

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

7 January 2021

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

1 reference

7 January 2021

Human papillomaviruses and associated malignancies

1 reference

7 January 2021

Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study

1 reference

7 January 2021

Detection of human papillomavirus DNA by the nucleic acid sandwich hybridization method from cervical scraping

1 reference

7 January 2021

Human papillomavirus detection by hybrid capture and its possible clinical use.

1 reference

7 January 2021

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

1 reference

7 January 2021

Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays

1 reference

7 January 2021

Comparison of two PCR-based human papillomavirus genotyping methods

1 reference

7 January 2021

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

7 January 2021

Natural history of cervical neoplasia: overview and update

1 reference

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

7 January 2021

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

1 reference

7 January 2021

Topographic study of cervical condyloma and intraepithelial neoplasia

1 reference

7 January 2021

Cervical Cancer Screening: From the Papanicolaou Smear to the Vaccine Era

1 reference

7 January 2021

The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix

1 reference

7 January 2021

Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions

1 reference

7 January 2021

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

1 reference

7 January 2021

Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study

1 reference

7 January 2021

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

1 reference

7 January 2021

Oncogenic Human Papillomavirus Infection and Cervical Lesions in Aboriginal Women of Nunavut, Canada

1 reference

7 January 2021

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study

1 reference

7 January 2021

Viral load of human papillomavirus and risk of CIN3 or cervical cancer.

1 reference

7 January 2021

Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri

1 reference

7 January 2021

Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia

1 reference

7 January 2021

Biomarkers in diagnostic obstetric and gynecologic pathology: a review

1 reference

7 January 2021

Diagnostic Accuracy of Cervical Low-Grade Squamous Intraepithelial Lesions Is Improved With MIB-1 Immunostaining

1 reference

7 January 2021

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers

1 reference

7 January 2021

Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis

1 reference

7 January 2021

p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types.

1 reference

7 January 2021

Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions

1 reference

7 January 2021

Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study.

1 reference

7 January 2021

Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.

1 reference

7 January 2021

Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma

1 reference

7 January 2021

Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia

1 reference

7 January 2021

[Immunocytochemistry (p16INK4a) as an additional examination for cytological specimens Class III D (Munich Classification II)]

1 reference

7 January 2021

Cross-reactivity of Trichomonas in cervical p16INK4a immunocytochemistry is dependent on antibody, not antigen

1 reference

7 January 2021

Trichomonas vaginalis P16 Immunoreactivity in cervicovaginal Pap tests: a diagnostic pitfall

1 reference

7 January 2021

Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia

1 reference

7 January 2021

MIB1, a promising marker for the classification of cervical intraepithelial neoplasia

1 reference

7 January 2021

Immunocytochemical Expression of p16INK4A and Ki-67 in Cytologically Negative and Equivocal Pap Smears Positive for Oncogenic Human Papillomavirus

1 reference

7 January 2021

Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses.

1 reference

7 January 2021

Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability

1 reference

7 January 2021

Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.

1 reference

7 January 2021

Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.

1 reference

7 January 2021

Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).

1 reference

7 January 2021

Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.

1 reference

7 January 2021

p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer

1 reference

7 January 2021

Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.

1 reference

7 January 2021

Automated detection and analysis of fluorescent in situ hybridization spots depicted in digital microscopic images of Pap-smear specimens

1 reference

7 January 2021

Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma

1 reference

7 January 2021

Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix

1 reference

7 January 2021

Host and viral genetics and risk of cervical cancer: a review

1 reference

7 January 2021

Human papillomavirus in cervical cancer screening: important role as biomarker

1 reference

7 January 2021

Cervical cancer control in the era of HPV vaccination and novel biomarkers

1 reference

7 January 2021

Identifiers

DOI

10.1002/DC.21270

1 reference

release_j4dbhhgxwbckbm2alp3e5bup54

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4dbhhgxwbckbm2alp3e5bup54

24 November 2022

mapped directly with Wikidata item

1 reference